06/05/2026
Researchers at KAIST are exploring a new cancer strategy focused on reprogramming tumor cells rather than destroying them. Using an AI based tool called BENEIN, scientists identified gene regulators linked to abnormal cancer behavior in colorectal tumors.
In laboratory and animal studies, altering specific genetic pathways reduced tumor growth and encouraged more normal tissue characteristics. Researchers reported promising changes in tumor markers and cell behavior.
Experts stress the treatment remains experimental and far from routine medical use.
📌 BOTTOM FACT
Cancer develops when cells lose normal growth controls and begin multiplying uncontrollably through genetic changes.
🔬 SOURCE
KAIST colorectal cancer reprogramming research using BENEIN
PMID: Not yet widely indexed / peer reviewed publication details pending
⚠️ DISCLAIMER
These findings are based on early laboratory and animal research and do not yet represent a proven human cancer treatment.